The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Astellas Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys, Inc. July 26, 2017 EyeGate Implodes as Eye Drug Flunks Phase II Test February 4, 2018 Rebiotix Continues Management Team Expansion With Appointment Of As Chief Business Officer June 19, 2017
Rebiotix Continues Management Team Expansion With Appointment Of As Chief Business Officer June 19, 2017
